Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optimega was a U.S. supplemental health and nutraceutical company that marketed drinkable omega-3 products, including Omega Shots formulations aimed at adults over 50 and prenatal use. Publicly available materials describe the business as founded in 2017 with a mission to improve convenience and absorption versus traditional fish-oil capsules. Its products were positioned as liquid omega-3 nutritional supplements for brain, heart, and general wellness support rather than prescription therapeutics. Available company-registry records indicate the legal entity Optimega LLC later became inactive, and there is no clear evidence of a current operating biotech or pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optimega.